Singapore’s state investor Temasek reports record portfolio value of $283 billion
- Singapore's state investment company Temasek said the net value of its portfolio grew to 381 billion Singapore dollars (around $283 billion) in the financial year ended March 31.
- The portfolio expansion came as Temasek's one-year shareholder return jumped to 24.53%, the company said.
- Mukul Chawla, Temasek's joint head for telecommunications, media and technology, said the company is "very optimistic" about China despite the changing regulatory environment.
In this article
- SE
- 22UA-DE
- 700-HK
- BABA
SINGAPORE — Singapore's state investment company Temasek said Tuesday the net value of its portfolio reached a record high in the financial year that ended March 31.
In its annual report, the investor said its portfolio grew to 381 billion Singapore dollars (around $283 billion) as of end-March. That's compared with 306 billion Singapore dollars a year ago, when the size of Temasek's portfolio fell for the first time since 2016.
The portfolio expansion came as Temasek's one-year shareholder return jumped to 24.53% in Singapore dollar terms, the company said. Returns were 7% over a 10-year period and 8% over 20 years, it added. Those returns took into account all dividends paid to Temasek's shareholder, minus any capital injections.
Temasek is owned by the government of Singapore.
During the financial year, Temasek invested 49 billion Singapore dollars and divested 39 billion Singapore dollars — record numbers on both counts.
Stock picks and investing trends from CNBC Pro:
Goldman says bet on these stocks with expanding profitability into earnings season
Top JPMorgan strategist Kolanovic says it's too early to ditch reopening stocks
If you think the global economy is about to expand, Morgan Stanley has some stocks for you
Temasek is an active equity investor in both the public and private space. The company invested mainly in Singapore companies in its early days, but has turned into a major global investor in recent years.
The company — a closely followed investor — has invested in major regional internet start-ups such as Singapore-based Sea and Indonesia's GoTo Group. It also has a stake in German biotech firm BioNTech, which developed a Covid-19 vaccine with American pharmaceutical giant Pfizer.
Regulatory risks in China
More than 60% of the assets held by Temasek's portfolio companies are in Asia, with Singapore and China as the top two markets in the region.
Temasek's exposure in China includes holdings in tech giants Tencent and Alibaba, which recently came under tighter regulatory scrutiny as Beijing moves to rein in monopolistic business practices.
Mukul Chawla, Temasek's joint head for telecommunications, media and technology, told CNBC that regulatory risks are not unique to China.
"We remain very optimistic on China, we remain very bullish around the growth prospects of China and the technology opportunities," said Chawla, who's also joint head for North America.
"The changing regulatory environment … is one of the risks we need to consider, we're faced with regulations not just in China but other parts of the world as well. So it doesn't change our stance in any meaningful way," he told CNBC's Sri Jegarajah after Temasek released its annual report.
Digitization is a major focus for the Singapore state investor. Temasek said that financial services remained its portfolio's largest segment, but its investments in the space has evolved over the last decade from mainly banks to include fintech and payments.
Source: Read Full Article